Safety and Efficacy of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Phase of Trial: Phase III
Latest Information Update: 24 May 2017
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Acronyms REVEAL 2
- Sponsors Allergan
- 07 Jun 2017 Biomarkers information updated
- 24 May 2017 Results from this and one other study (NCT02131636) assessing the Impact Assessment for Rosacea Facial Redness (IA-RFR) outcome, presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
- 19 Jan 2017 According to an Allergan media release, based on the data from the study, the U.S. Food and Drug Administration (FDA) has approved RHOFADE cream for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults.